J M Palefsky

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men
    J M Palefsky
    Department of Laboratory Medicine, University of California, San Francisco, 94143, USA
    J Infect Dis 177:361-7. 1998
  2. ncbi Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
    J M Palefsky
    Department of Laboratory Medicine, University of California, San Francisco 94143, USA
    J Natl Cancer Inst 91:226-36. 1999
  3. ncbi Prevalence and risk factors for anal squamous intraepithelial lesions in women
    E A Holly
    Department of Epidemiology and Biostatistics, University of California, San Francisco 94143 1228, USA
    J Natl Cancer Inst 93:843-9. 2001
  4. ncbi Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
    J M Palefsky
    Departments of Laboratory Medicine, Medicine, and Stomatology, University of California, San Francisco, CA 94143 0100, USA
    J Infect Dis 183:383-91. 2001
  5. ncbi Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection
    J M Palefsky
    Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Acquir Immune Defic Syndr 28:422-8. 2001
  6. ncbi Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV-positive and HIV-negative men
    T Haga
    Department of Laboratory Medicine, University of California San Francisco, 94143, USA
    J Acquir Immune Defic Syndr 26:256-62. 2001
  7. ncbi Expression of Epstein-Barr virus BMRF-2 and BDLF-3 genes in hairy leukoplakia
    M E Penaranda
    Department of Stomatology, University of California, San Francisco 94143, USA
    J Gen Virol 78:3361-70. 1997
  8. ncbi Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51
    J Tonna
    School of Medicine, University of California, San Francisco, California, USA
    Dis Esophagus 23:E17-20. 2010
  9. ncbi Type I collagen degradation by invasive oral squamous cell carcinoma
    B L Ziober
    Department of Stomatology, University of California San Francisco, Box 0512, 521 Parnassus Avenue, San Francisco, CA 94143, USA
    Oral Oncol 36:365-72. 2000
  10. ncbi CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses
    M Nakagawa
    Departments of Laboratory Medicine, Schools of Medicine and Dentistry, University of California at San Francisco, San Francisco, California 94143, USA
    Clin Diagn Lab Immunol 6:494-8. 1999

Collaborators

Detail Information

Publications11

  1. ncbi Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men
    J M Palefsky
    Department of Laboratory Medicine, University of California, San Francisco, 94143, USA
    J Infect Dis 177:361-7. 1998
    ..004) but not group A DNA. These data suggest increased replication of the more oncogenic HPV types with more advanced immunosuppression...
  2. ncbi Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
    J M Palefsky
    Department of Laboratory Medicine, University of California, San Francisco 94143, USA
    J Natl Cancer Inst 91:226-36. 1999
    ....
  3. ncbi Prevalence and risk factors for anal squamous intraepithelial lesions in women
    E A Holly
    Department of Epidemiology and Biostatistics, University of California, San Francisco 94143 1228, USA
    J Natl Cancer Inst 93:843-9. 2001
    ..Our aim was to determine the prevalence of human papillomavirus (HPV)-related abnormalities of the anal canal in women and to characterize risk factors for these lesions...
  4. ncbi Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
    J M Palefsky
    Departments of Laboratory Medicine, Medicine, and Stomatology, University of California, San Francisco, CA 94143 0100, USA
    J Infect Dis 183:383-91. 2001
    ..80; 95% CI, 0.50-0.99), as did African American women (RR, 0.86; 95% CI, 0.72-1.0), compared with white women. Anal HPV infection is underrecognized in HIV-positive and high-risk HIV-negative women...
  5. ncbi Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection
    J M Palefsky
    Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Acquir Immune Defic Syndr 28:422-8. 2001
    ..The ASIL and HPV data were similar to those of the pre-HAART comparison period. These results indicate that HAART has little effect on either ASIL or HPV in the first 6 months after HAART initiation...
  6. ncbi Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV-positive and HIV-negative men
    T Haga
    Department of Laboratory Medicine, University of California San Francisco, 94143, USA
    J Acquir Immune Defic Syndr 26:256-62. 2001
    ..This alteration was previously reported to be commonest alteration in cervical cancer, which suggests a common molecular pathway for these two HPV-associated anogenital neoplasias...
  7. ncbi Expression of Epstein-Barr virus BMRF-2 and BDLF-3 genes in hairy leukoplakia
    M E Penaranda
    Department of Stomatology, University of California, San Francisco 94143, USA
    J Gen Virol 78:3361-70. 1997
    ..BDLF-3 protein expression was observed in the perinuclear space and cytoplasm of the prickle cells. BDLF-3 has recently been identified as a virion-associated protein, but the functions of BMRF-2 and BDLF-3 have not been elucidated...
  8. ncbi Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51
    J Tonna
    School of Medicine, University of California, San Francisco, California, USA
    Dis Esophagus 23:E17-20. 2010
    ....
  9. ncbi Type I collagen degradation by invasive oral squamous cell carcinoma
    B L Ziober
    Department of Stomatology, University of California San Francisco, Box 0512, 521 Parnassus Avenue, San Francisco, CA 94143, USA
    Oral Oncol 36:365-72. 2000
    ..Together, these results indicate that MMP-1 is expressed, induced by EGF, and required for type I collagen degradation in oral squamous cell carcinoma...
  10. ncbi CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses
    M Nakagawa
    Departments of Laboratory Medicine, Schools of Medicine and Dentistry, University of California at San Francisco, San Francisco, California 94143, USA
    Clin Diagn Lab Immunol 6:494-8. 1999
    ..On the other hand, natural killer cells in the effector cell population contribute to background activities but not to HPV-specific responses in this assay system...
  11. ncbi Integrin expression in oral hairy leukoplakia and normal tongue epithelium
    N Chainani-Wu
    Department of Stomatology, University of California, San Francisco, San Francisco, CA 94143, USA
    Oral Dis 6:234-40. 2000
    ..To describe the expression of integrins in the epithelium of oral hairy leukoplakia (HL) and compare to that of normal lateral tongue epithelium...